A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy
(Q46972403)
scientific article published in October 2007
scientific article published in October 2007
Language:
Current Data About
A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy
other details
| description | scientific article published in October 2007 |
External Links
| (P356) |
10.1016/J.OPHTHA.2007.03.050
|
| (P698) |
17908591
|